Related Experiment Video

Updated: Jul 19, 2026

Modeling Chemotherapy Resistant Leukemia In Vitro
08:41

Modeling Chemotherapy Resistant Leukemia In Vitro

Published on: February 9, 2016

Mathematical modeling of cancer progression and response to chemotherapy

Sandeep Sanga1, John P Sinek, Hermann B Frieboes

  • 1University of California, Department of Biomedical Engineering, Irvine, 3120, CA 92697-2715, USA. ssanga@uci.edu

Expert Review of Anticancer Therapy
|October 31, 2006
PubMed

Insights

Mathematical modeling and computer simulation offer a robust framework for understanding cancer progression and chemotherapy response. A multiscale simulator can efficiently screen drug candidates, accelerating cancer therapy development.

Area of Science:

  • Oncology
  • Computational Biology
  • Pharmacology

Background:

  • Cancer's complexity and heterogeneity impede targeted therapy development.
  • Understanding molecular and pathophysiological signatures is crucial for effective cancer treatment.
  • Biological barriers at multiple scales challenge therapeutic agent delivery.

Purpose of the Study:

  • To develop a multiscale computer simulator for analyzing cancer progression and chemotherapy response.
  • To establish a technology platform for evaluating chemotherapeutic drug effectiveness.
  • To provide a cost-effective and efficient method for screening drug candidates.

Main Methods:

  • Integration of experimental data with mathematical models.
  • Development of a multiscale computer simulation framework.
  • Analysis of biological barriers and drug target concentrations.

Main Results:

  • The simulator provides insights into cancer progression and chemotherapy response.
  • The platform facilitates the analysis of chemotherapeutic drug effectiveness.
  • The approach has the potential for cost-effective drug candidate screening.

Conclusions:

  • Multiscale modeling and simulation are valuable tools for cancer research.
  • This technology platform can accelerate the development of novel cancer therapies.
  • Integrating experimental data and mathematical models is key to advancing oncology drug discovery.

Related Concept Videos

Cancer Survival Analysis01:21

Cancer Survival Analysis

Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
Tumor Progression02:07

Tumor Progression

Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Fundamental Mathematical Principles in Pharmacokinetics: Calculus and Graphs01:21

Fundamental Mathematical Principles in Pharmacokinetics: Calculus and Graphs

The fundamental mathematical principles, such as calculus and graphs, play crucial roles in analyzing drug movement and determining pharmacokinetic parameters. Differential calculus examines rates of change and helps to determine the dissolution rate of drugs in biofluids, as well as how drug concentrations change over time. For instance, it can help calculate the rate of elimination of a drug from the body based on its concentration-time profile.
On the other hand, integral calculus focuses on...
Model Approaches for Pharmacokinetic Data: Distributed Parameter Models01:06

Model Approaches for Pharmacokinetic Data: Distributed Parameter Models

Pharmacokinetic models are mathematical constructs that represent and predict the time course of drug concentrations in the body, providing meaningful pharmacokinetic parameters. These models are categorized into compartment, physiological, and distributed parameter models.
The distributed parameter models are specifically designed to account for variations and differences in some drug classes. This model is particularly useful for assessing regional concentrations of anticancer or...
Treatment Resistant Cancers02:56

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...